24
FEATURE:
DEPARTMENTS
TRANSCELERATE
6
8
10
Dalvir Gill, Ph.D., CEO of TransCelerate BioPharma,
reveals the biggest roadblock to TransCelerate's success
and how it was overcome.
14
16
20
42
44
January 2014
CONTENTS
Welcome to
Life Science Leader
46
49
50
30
34
A RARE-DISEASE
CHAMPION
Capitol Perspectives
Obamacare & Retiree Drug Coverage
Companies To Watch
Protagonist Therapeutics
Outsourcing Insights
What Drives Partner Selection
Bio Innovation Notes
Who Is Improving Bioprocessing?
Pharma Manufacturing
cGMP Issues Are Increasing
Biopharm Dev. & Manufacturing
Biotechs Are Booming
R&D; and Clinical Trials
Training Asian Workers
Industry Leader
"Type 3" Diabetes On Trial
Leadership Lessons
Different Communication Methods
PHARMA: TARGET
FOR TERRORISM
Rogerio Vivaldi discusses his long
history with rare-disease therapies
and drug development.
Editorial Board/Ask The Board
38
SMALL COMPANIES,
BIG INNOVATIONS
Editor's Note
How can you reduce your risk of
counterfeiting, adulteration, and
diverted products?
The second part in our series looking at
the successes and challenges of three
"micro-innovators"
@RFWrightLSL
linkedin.com/in/robertfwright
pinterest.com/rfwrightlsl
facebook.com/LifeScienceLeader
4
LifeScienceLeader.com
January 2014